Ready To Welcome To...
Health Care: Drugs
Arena Pharmaceuticals Inc. (ARNA: NASDAQ)
$8.30 0.24 | 2.99%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -85.48M | -109.22M | -124.53M | -153.20M |
| Operating Gains/Losses | 6.31M | 10.48M | 7.97M | -2.63M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.26M | 2.88M | -1.93M | 430.00K |
| (Increase) Decrease in Inventories | -5.88M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 276.00K | -1.12M | -5.64M | -28.76M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 17.75M | -3.58M | 43.84M | -92.00K |
| Other Non-Cash Items | 18.50M | 10.20M | 13.28M | 14.86M |
| Net Cash From Continuing Operations | -44.05M | -78.26M | -52.32M | -155.92M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -44.05M | -78.26M | -52.32M | -155.92M |
| Sale of Property, Plant & Equipment | 31.00K | 33.00K | 47.00K | 263.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 21.66M | 36.70M |
| Purchases of Property, Plant & Equipment | -1.78M | -619.00K | -4.21M | -5.33M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -1.23M | -20.43M |
| Other Cash from Investing Activities | -425.00K | -86.00K | 48.00K | 170.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -2.17M | -672.00K | 16.32M | 11.36M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 111.86M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 167.68M | 35.64M | 120.47M | 65.37M |
| Repayment of Long-Term Debt | -23.57M | -49.80M | -30.72M | -10.58M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 144.11M | -14.16M | 89.75M | 166.65M |
| Effect of Exchange Rate Changes | 571.00K | 50.00K | 2.18M | -688.00K |
| Net Change in Cash & Cash Equivalents | 98.46M | -93.04M | 55.94M | 21.40M |
Portfolios with ARNA
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- UserMy Watch List
- Usermichelle
- User2012 picks 10/28/20121
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- UserMy SP portfolio
- UserMyfuture
- ContributorStocks Under-$10 Setting Up...
Latest ARNA Headlines from TheStreet
- Happy Day for Arena Bulls, Bears As Belviq Launch Finally Arrives 05.07.13 | 11:05 am
- Arena Stock Gaps Down On Today's Open (ARNA) 05.03.13 | 09:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Large Vivus Shareholder Seeks More Change 04.10.13 | 10:04 am
- Arena Bulls, Bears Endure Annoyingly Long Wait for Belviq Launch 04.10.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Vivus Piles New Debt On Top Of Excuses 03.26.13 | 10:03 am
- Arena Pharmaceuticals Inc. (ARNA): Health Care's Featured Stock Of The Day 03.25.13 | 05:03 pm
- 2 Drug Stocks Under $10 To Pick As Favorites 03.25.13 | 02:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
Press Releases for ARNA
- Pill Economics - Research Report On Arena Pharmaceuticals, Inc. And Amgen, Inc. - PR Newswire 01.23.13 | 08:01 am
- Stock Alerts For Coca-Cola, Deere, News Corp., Arena Pharmaceuticals, And American Tower Released By InvestorsObserver - PR Newswire 06.28.12 | 09:06 am
- Arena Pharmaceuticals Investigated By Goldfarb Branham Law Firm LLP - Business Wire 10.08.10 | 09:10 am
- Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) - Business Wire 09.29.10 | 05:09 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) - Business Wire 09.28.10 | 02:09 pm
- Investor Notice: The Rosen Law Firm Announces Filing Of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA - Business Wire 09.22.10 | 06:09 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 05:09 pm
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of Arena Pharmaceuticals, Inc. - Business Wire 09.22.10 | 12:09 pm
Partner Headlines for ARNA
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- Fannie Mae And Freddie Mac, Short-Term Trade Or Deep Value Investment? - Seeking Alpha 03.25.13 | 09:03 am
- A Look At 3 Obesity Stocks - Seeking Alpha 03.05.13 | 09:03 am
- Trius Therapeutics: New MSRA Treatment Could Bring Billions In Revenues - Seeking Alpha 03.05.13 | 09:03 am
- Pre-Market Earnings Report for March 4, 2013 : RIG, SSYS, TECD, ARNA, CEL, BYD, YGE, ALVR - NASDAQ 03.01.13 | 09:03 pm
- Arena's Recent Outperform Call And A Probability Weighted Valuation - Seeking Alpha 02.08.13 | 08:02 am
- Arena Must Wait For European Approval - Seeking Alpha 01.19.13 | 07:01 am
- Orexigen: The Best Bet In Obesity For 2013 - Seeking Alpha 12.17.12 | 09:12 am
- Arena Opening New Doors - Seeking Alpha 11.29.12 | 09:11 am
